Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by M. O. Fofana
Reply to Anthony Et Al., “Protecting Pyrazinamide, a Priority for Improving Outcomes in Multidrug-Resistant Tuberculosis Treatment”
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Related publications
Pyrazinamide May Improve Fluoroquinolone-Based Treatment of Multidrug-Resistant Tuberculosis
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Erratum for Velásquez Et Al., Pyrazinamide Resistance Assays and Two-Month Sputum Culture Status in Patients With Multidrug-Resistant Tuberculosis
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Value of Pyrazinamide for Composition of New Treatment Regimens for Multidrug-Resistant Mycobacterium Tuberculosis in China
BMC Infectious Diseases
Infectious Diseases
Treatment Outcomes of Multidrug-Resistant Tuberculosis: A Systematic Review and Meta-Analysis
PLoS ONE
Multidisciplinary
Treatment Outcomes of Rifabutin-Containing Regimens for Rifabutin-Sensitive Multidrug-Resistant Pulmonary Tuberculosis
International Journal of Infectious Diseases
Medicine
Infectious Diseases
Microbiology
Revolutionary New Treatment Regimens for Multidrug-Resistant Tuberculosis
The Lancet Infectious Diseases
Infectious Diseases
Clofazimine for the Treatment of Multidrug-Resistant Tuberculosis
Clinical Microbiology and Infection
Medicine
Infectious Diseases
Microbiology
Multidrug-Resistant Tuberculosis Treatment Outcomes in Karakalpakstan, Uzbekistan: Treatment Complexity and XDR-TB Among Treatment Failures
PLoS ONE
Multidisciplinary
Bedaquiline: New Approach for Treatment of Multidrug-Resistant Tuberculosis
RUHS Journal of Health Science
